SLC7A11 Expression in Lung Cancer Linked to HPV and Smoking
Author Information
Author(s): Osorio Julio C., Andrade-Madrigal Cristian, Gheit Tarik, Corvalán Alejandro H., Aguayo Francisco, Fujimuro Masahiro
Primary Institution: Laboratorio de Oncovirología, Departamento de Ciencias Biomédicas, Facultad de Medicina, Universidad de Tarapacá, Arica, Chile
Hypothesis
Is SLC7A11 up-regulation associated with HPV infection and tobacco smoke exposure in lung cancer?
Conclusion
The study found that SLC7A11 is frequently up-regulated in lung cancer patients with HPV infection and tobacco exposure, correlating with poorer survival rates.
Supporting Evidence
- HPV was detected in 4% of lung carcinomas in the study cohort.
- SLC7A11 was found to be up-regulated in HPV-positive lung carcinomas.
- Patients with high SLC7A11 expression had decreased survival rates.
- Significant differences in SLC7A11 expression were observed between smokers and non-smokers.
Takeaway
This study shows that a gene called SLC7A11 is more active in lung cancer patients who have HPV or smoke, which might make their cancer worse.
Methodology
The study evaluated HPV presence in 204 lung cancer cases using multiplex PCR and analyzed gene expression profiles through transcriptomic approaches.
Potential Biases
Potential biases may arise from the selection of cases and the reliance on archived clinical material.
Limitations
The study is limited by the small number of HPV-positive cases and the retrospective nature of the analysis.
Participant Demographics
The study included 204 lung cancer patients from Chile, comprising 105 adenocarcinomas and 99 squamous cell carcinomas.
Statistical Information
P-Value
p = 0.0080
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website